50 Clarence Street
Suite 506 Level 5
Sydney, NSW 2000
Australia
61 2 9078 7671
https://www.bcaldiagnostics.com
Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Ms. Jayne Andrea Shaw | Co-Founder & Executive Chairman | 180k | N/A | N/A |
Hon. Ronald Anthony Phillips A.O. | Co-Founder & Non-Executive Director | 52,31k | N/A | N/A |
Dr. Amani Batarseh Ph.D. | Chief Scientist Officer | 338,91k | N/A | N/A |
Mr. Shane Ryan M.B.A. | Chief Executive Officer | N/A | N/A | N/A |
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD | CFO & Company Secretary | N/A | N/A | 1953 |
Sean Kennedy | Director of Corporate Finance | N/A | N/A | N/A |
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a non-invasive blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from patient's blood plasma to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
BCAL Diagnostics Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.